This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
🎯 Background & Rationale
- Clinical dogma: Active pulmonary infection is traditionally considered an absolute contraindication to endobronchial valve (EBV) placement due to fears of trapping secretions and worsening sepsis.
- Persistent air leaks: Management of alveolar-pleural fistulas exceeding 5 days remains a major thoracic morbidity, often leaving frail patients with limited options.
- Evidence gap: Large-scale data comparing EBV outcomes in infected versus non-infectious air leaks have been lacking, prompting this national analysis.
👥 Study Design & Population
- Study type: Retrospective national cohort study utilizing the National Inpatient Sample database from 2016 to 2023.
- Population: Weighted total of 1,760 adult hospitalizations undergoing bronchoscopic EBV placement for persistent air leaks or pneumothorax.
- Cohorts: Stratified into non-infectious air leaks (52.6%) and complex pleuropulmonary infections including necrotizing pneumonia, lung abscess, or empyema (47.4%).
📈 Methodology & Rigor
- Exclusion filters: Rigorously excluded elective admissions, same-day procedures on admission, and cases with missing or invalid procedural dates to ensure proper temporal sequencing.
- Statistical approach: Utilized multivariable logistic regression to identify independent predictors of composite clinical failure while adjusting for disease severity, mechanical ventilation, and comorbidities.
- Administrative limitations: Relied on ICD-10 coding, which resulted in a high rate of uncodable microbiological data (69.5%) and limited granular procedural details.
🔬 Key Findings [or Planned Endpoints]
- Primary failure rate: Complex infection was not independently associated with composite clinical failure after multivariable adjustment (P = 0.994).
- Mechanical ventilation: Positive pressure ventilation was independently associated with an increased odds of clinical failure (aOR 3.00, P < 0.001).
- Pathogen-specific risk: Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia was associated with approximately fourfold higher odds of composite clinical failure (aOR 3.90, P = 0.030).
- Resource utilization: The infection cohort experienced significantly longer length of stay (24.9 vs 16.0 days, P < 0.001) and higher hospital costs ($93,817 vs $46,669, P < 0.001).
- Device retrieval: Valve extraction rates were higher in the complex infection cohort compared to non-infectious controls (12.6% vs 5.4%).
⚖️ Critical Appraisal
- Confounding factors: Patients with complex infections presented with significantly higher baseline severity of illness (71.3% APR-DRG extreme tier vs 25.9%), reflecting advanced disease complexity.
- Coding granularity: Administrative datasets lack anatomical specificity to confirm whether EBVs were deployed directly into the infected lobe or whether leaks were remote from the infection.
- Selection bias: Post-surgical infectious salvage cases demonstrated markedly worse unadjusted outcomes, representing a distinctly higher-risk phenotype that warrants careful patient selection.
💡 The Clinical Bottom Line
- Reevaluating dogma: Active pleuropulmonary infection should not be viewed as an absolute contraindication to EBV placement when aggressive pleural drainage is established.
- Patient selection: Interventional pulmonologists can cautiously offer EBVs as a bridge-to-healing in infected, non-surgical candidates, though mechanical ventilation and MRSA bacteriology signal significantly higher failure rates.
- Practice takeaway: Ensure meticulous pleural source control before deployment, and anticipate a higher requirement for secondary device adjustments or extractions in infected fields.
Abstract
Keep reading
N opens the next oneClinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
CT-guided fiducial placement remains a relevant technique for pre-procedural localization of peripheral lung lesions.
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
For interventional pulmonologists, remimazolam offers a favorable safety profile with significantly reduced respiratory depression (RR 0.51, 95% CI 0.36 to 0.73, P < 0.001) alongside rapid recovery and procedural efficiency.